Mepron

Mepron is a brand name of atovaquone, approved by the FDA in the following formulation(s):

MEPRON (atovaquone - suspension; oral)

• 
  Manufacturer: GLAXOSMITHKLINE LLC
  
  Approval date: February 8, 1995
  
  Strength(s): 750MG/5ML ^[RLD]

Has a generic version of Mepron been approved?

No. There is currently no therapeutically equivalent version of Mepron available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Mepron. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Atovaquone pharmaceutical compositions
  Patent 6,649,659
  Issued: November 18, 2003
  Inventor(s): Alan Roy; Dearn
  Assignee(s): SmithKline Beecham Corporation
  The invention relates to a process for the production of microfluidized particles of atovaquone having improved bioavailability.
  
  Patent expiration dates:
  
  
  • July 10, 2016
    
    ✓ 
    Patent use: TREATMENT OF PNEUMOCYSTIS CARINII INFECTIONS
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  
  
  • January 10, 2017
    
    ✓ 
    Pediatric exclusivity
  
  

See also...

• Mepron Consumer Information (Wolters Kluwer)
• Mepron Consumer Information (Cerner Multum)
• Mepron Advanced Consumer Information (Micromedex)
• Mepron AHFS DI Monographs (ASHP)
• Atovaquone Consumer Information (Wolters Kluwer)
• Atovaquone Consumer Information (Cerner Multum)
• Atovaquone Advanced Consumer Information (Micromedex)
• Atovaquone AHFS DI Monographs (ASHP)